心脏发作性冲击4蛋白 (CS4P) 预测模型在心脏病发作相关心脏发作性冲击中的预测性能
Danilo Obradovic1, Lisa Schulz2, Goran Loncar3,4
1Department for Internal Medicine and Cardiology, Heart Centre Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.
ESC heart failure
|February 19, 2026
概括
心脏性休克4蛋白 (CS4P) 风险评分有效地分层了急性心肌梗塞患者的死亡风险. 它显示ST段升高心肌梗塞 (STEMI) 的预后优于非STEMI,特别是没有先前心肺复苏 (CPR).
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 预测模型的预测建模
背景情况:
- CS4P风险评分显示,在各种病因方面,对心脏性休克 (CS) 有很强的预测能力.
- 有限的数据存在于CS4P的表现在CS患者不同的急性冠状动脉综合征 (ACS) 类型.
研究的目的:
- 为了评估CS4P风险评分的预后价值,CS患者的ST段升高心肌梗塞 (STEMI) 与非STEMI.
- 为了评估CS4P得分在STEMI患者的表现,先前有或没有心肺复苏 (CPR).
主要方法:
- 对CULPRIT-SHOCK试验数据的后期分析.
- 通过ELISA测定测量血清CS4P标记物.
- 主要结局:30天死亡率组合或替代疗法.
主要成果:
- 在CS4P得分中,STEMI (AUC 0.74) 的预后比NSTEMI (AUC 0.69) 的CS患者更好.
- 在没有先前心肺复苏 (AUC 0.78) 的STEMI患者的预后表现高于心肺复苏 (AUC 0.70) 的患者.
- 最高的CS4P三位数与增加的30天死亡率相关 (HR 1.42).
结论:
- CS4P评分为急性心肌梗塞相关的CS提供了可接受的短期死亡风险分层.
- 与NSTEMI相比,CS4P模型为STEMI患者提供了更好的预后.
- 在没有进行心肺复苏的STEMI患者中,预后性能得到改善.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
959
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
959
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
952
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
952
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
625
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
625